These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35475755)

  • 21. BMI z-Scores are a poor indicator of adiposity among 2- to 19-year-olds with very high BMIs, NHANES 1999-2000 to 2013-2014.
    Freedman DS; Butte NF; Taveras EM; Lundeen EA; Blanck HM; Goodman AB; Ogden CL
    Obesity (Silver Spring); 2017 Apr; 25(4):739-746. PubMed ID: 28245098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z; Xu M; Hu Z; Shrestha UK
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease.
    Fujiwara M; Eguchi Y; Fukumori N; Eguchi H; Tomonaga M; Yoshioka T; Hyakutake M; Sakanishi Y; Kyoraku I; Sugioka T; Fujimoto K; Kusano M; Yamashita S
    Intern Med; 2015; 54(24):3099-104. PubMed ID: 26666594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal changes in BMI z-scores among 45 414 2-4-year olds with severe obesity.
    Freedman DS; Butte NF; Taveras EM; Goodman AB; Blanck HM
    Ann Hum Biol; 2017 Dec; 44(8):687-692. PubMed ID: 29082754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BMI metrics and their association with adiposity, cardiometabolic risk factors, and biomarkers in children and adolescents.
    Bramante CT; Palzer EF; Rudser KD; Ryder JR; Fox CK; Bomberg EM; Bensignor MO; Gross AC; Sherwood NE; Kelly AS
    Int J Obes (Lond); 2022 Feb; 46(2):359-365. PubMed ID: 34718333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Adolescent Obesity with Nonalcoholic Fatty Liver Disease and Related Risk Factors in Xi 'an, China.
    Rong Y; Chun-Yan N; Hong-Xin Z; Lu Y; Wen W; Yu T
    Ann Hepatol; 2018; 17(1):85-91. PubMed ID: 29311392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The association between body mass index and non-alcoholic fatty liver disease].
    Yu XY; Zhao Y; Song XX; Song ZY
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 43(5):546-52. PubMed ID: 25372639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity.
    Zhang J; Cao J; Xu H; Dong G; Huang K; Wu W; Ye J; Fu J
    J Clin Lab Anal; 2021 Feb; 35(2):e23602. PubMed ID: 33249617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.
    Rigor J; Diegues A; Presa J; Barata P; Martins-Mendes D
    Postgrad Med; 2022 May; 134(4):435-440. PubMed ID: 35332833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of non-alcoholic fatty liver disease in obese children.
    Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
    Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships Between Alanine Aminotransferase, Serum Triglycerides, Body Mass Index and Nonalcoholic Fatty Liver Disease in an Outpatient Pediatric Clinic Population.
    Cohen D; Gonzales-Pacheco D; Myers O
    J Pediatr Nurs; 2016; 31(2):152-8. PubMed ID: 26690717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
    BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening patterns and identification of non-alcoholic fatty liver disease in obese children in canadian primary care.
    Theal R; Morkem R; Queenan J; Barber D
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.
    Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Elevated ALT in Adolescents in the US 2011-2018.
    Mischel AK; Liao Z; Cao F; Dunn W; Lo JC; Newton KP; Goyal NP; Yu EL; Schwimmer JB
    J Pediatr Gastroenterol Nutr; 2023 Jul; 77(1):103-109. PubMed ID: 37084344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease.
    Seth A; Orkin S; Yodoshi T; Liu C; Fei L; Hardy J; Trout AT; Arce Clachar AC; Bramlage K; Xanthakos S; Mouzaki M
    Pediatr Obes; 2020 Feb; 15(2):e12581. PubMed ID: 31657145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis.
    Abeysekera KWM; Orr JG; Gordon FH; Howe LD; Hamilton-Shield J; Heron J; Hickman M
    BMC Gastroenterol; 2022 Jun; 22(1):323. PubMed ID: 35773644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German/Austrian/Swiss obesity registry APV.
    Greber-Platzer S; Thajer A; Bohn S; Brunert A; Boerner F; Siegfried W; Artlich A; Moeckel A; Waldecker-Krebs H; Pauer S; Holl RW;
    BMC Pediatr; 2019 Sep; 19(1):332. PubMed ID: 31514755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Predictors of Nonalcoholic Fatty Liver Disease in Family Members of Patients With Nonalcoholic Fatty Liver Disease.
    Anand A; Singh AA; Elhence A; Vaishnav M; Biswas S; Gunjan D; Gamanagatti SR; Nayak B; Kumar R; Shalimar
    J Clin Exp Hepatol; 2022; 12(2):362-371. PubMed ID: 35535086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of INSIG2 rs9308762 with ALT level independent of BMI.
    Guan L; Shang XR; Liu FH; Song JY; Ma J; Wang HJ
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):155-9. PubMed ID: 24458218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.